VEA
IRMD icon

Virtus ETF Advisers’s iRadimed IRMD Stock Holding History

Virtus ETF Advisers’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$179K Buy
1,875
+225
+14% +$20.5K 0.07% 296
2026
Q1 		$159K Hold
1,650
– – 0.07% 281
2025
Q4 		$161K Hold
1,650
– – 0.08% 281
2025
Q3 		$117K Hold
1,650
– – 0.06% 297
2025
Q2 		$98.7K Buy
+1,650
New +$90.4K 0.06% 295

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Virtus ETF Advisers's IRMD Position: Q2 2026 in Review

Virtus ETF Advisers increased its iRadimed (IRMD) stake by 14% in Q2 2026, buying an estimated $20.5K and bringing the position to 1,875 shares worth $179K. The position accounts for 0.07% of the portfolio, ranked #296.

Virtus ETF Advisers first reported a position in IRMD in Q2 2025 and has held it in 5 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Virtus ETF Advisers held 1,875 shares of iRadimed worth $179K as of Q2 2026.
  • Virtus ETF Advisers bought 225 iRadimed shares in Q2 2026, an estimated $20.5K.
  • iRadimed made up 0.07% of Virtus ETF Advisers's portfolio in Q2 2026, its #296 holding.
  • Virtus ETF Advisers first reported a position in iRadimed in Q2 2025 and has held it in 5 quarters since.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.